Science Explorer Interactive view Map
Company · Durham · United States

BioCryst Pharmaceuticals (United States)

biocryst.comROR OpenAlex
World rank, all time
#30,423
of 42,892
Rank in United States
#6,526
of 8,685
Research works
172
▲ 81% vs 2013–17
Citations
4.1k
24.0 per fractional work
Top-10% rate
3.7%
record average 16.5%
Open access
31%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.87× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 8.72× its world share, 2 worksImmunology and Micro…Chemistry: 8.61× its world share, 3 worksChemistryHealth Professions: 0.77× its world share, 0 worksHealth ProfessionsMedicine: 3.27× its world share, 14 worksMedicineNursing: 0.77× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.07× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.18× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.7×. Every wedge is a field page.

Who are the top researchers at BioCryst Pharmaceuticals (United States)?

Ranked on the composite score, William Sheridan, Y.S. Babu and Pravin L. Kotian lead among researchers whose main affiliation is BioCryst Pharmaceuticals (United States).

  1. 1 William Sheridan United States · #145,072 worldwide 165 citations · 28 works
  2. 2 Y.S. Babu United States · #379,649 worldwide 131 citations · 20 works
  3. 3 Pravin L. Kotian United States · #903,154 worldwide 77 citations · 16 works
All ranked researchers at BioCryst Pharmaceuticals (United States)

Which keywords describe research at BioCryst Pharmaceuticals (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Hereditary Angioedema, Kinin Receptor Family, Innate Immunity, Complement, Immune, Factor VIII, Hemophilia and Absolute Configuration.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Hereditary Angioedema6▲ 1422×1 topic
  2. Kinin Receptor Family6▲ 1422×1 topic
  3. Innate Immunity2▲ 24×2 topics
  4. Epidemiology2▲ 1.87×9 topics
  5. Complement1▲ 363×1 topic
  6. Immune1▲ 363×1 topic
  7. Cancer1▲ 4.0×3 topics
  8. Absolute Configuration1▲ 358×1 topic
  9. Amination1▲ 277×1 topic
  10. Antiretroviral Therapy1▲ 28×1 topic
  11. Catalytic1▲ 38×1 topic
  12. Chiroptical Spectroscopy1▲ 358×1 topic
  13. Factor VIII1▲ 319×1 topic
  14. HIV Infection1▲ 44×1 topic
  15. Hemophilia1▲ 319×1 topic
  16. Inflammation1▲ 2.2×3 topics

Which research topics does BioCryst Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Coagulation, Bradykinin, Polyphosphates, and Angioedema, Complement system in diseases, Molecular spectroscopy and chirality and Synthesis and Catalytic Reactions.

Coagulation, Bradykinin,…6Coagulation, Bradykinin, Polyphosphates, and Angioedema: 6 fractional worksComplement system in diseases: 1 fractional worksMolecular spectroscopy and chirality: 1 fractional worksSynthesis and Catalytic Reactions: 1 fractional worksHIV/AIDS drug development and treatment: 1 fractional worksHemophilia Treatment and Research: 1 fractional worksBiochemical and Molecular Research: 1 fractional worksPI3K/AKT/mTOR signaling in cancer: 1 fractional worksChronic Myeloid Leukemia Treatments: 1 fractional worksRenal Diseases and Glomerulopathies: 0 fractional works
GeneticsImmunologySpectroscopyOrganic Chemistry4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 6 works
  2. 2 Complement system in diseases Immunology 1 works
  3. 3 Molecular spectroscopy and chirality Spectroscopy 1 works
  4. 4 Synthesis and Catalytic Reactions Organic Chemistry 1 works
  5. 5 HIV/AIDS drug development and treatment Infectious Diseases 1 works
  6. 6 Hemophilia Treatment and Research Hematology 1 works
  7. 7 Biochemical and Molecular Research Molecular Biology 1 works
  8. 8 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
  9. 9 Chronic Myeloid Leukemia Treatments Hematology 1 works
  10. 10 Renal Diseases and Glomerulopathies Nephrology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.3%not open68.7%

World: 28% of research is openly available.

with international co-authors14.6%domestic only85.4%

World: 19% is written across borders.

How has BioCryst Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 81% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Durham

All research institutions in Durham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.